Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study
A prognostic benefit of additive chemotherapy in patients following resection of metachronous colorectal liver metastases (CRLM) remains controversial. Therefore, the goal of this retrospective study was to in...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Matthias Kelm, Julia Schollbach, Friedrich Anger, Armin Wiegering, Ingo Klein, Christoph-Thomas Germer, Nicolas Schlegel, Volker Kunzmann and Stefan L öb Tags: Research article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Liver | Study | Urology & Nephrology